Purchase Order 15B41226P00000018
- Not listed
- McKesson Corporation received a $2,243.27 firm fixed-price purchase order from the Federal Medical Center Rochester on October 1, 2025, with an ultimate completion date of December 5, 2025. This open market controlled acquisition was issued with no set-aside designation and represents a direct procurement for medical or pharmaceutical supplies to support the correctional healthcare facility's operations. The place of performance is McKesson's headquarters in Irving, Texas, positioning the...
- The Federal Bureau of Prisons' Federal Medical Center Rochester awarded a $6,500 firm fixed-price purchase order to McKesson Corporation on December 17, 2025, with an ultimate completion date of the same day. This open-market, non-set-aside contract represents a delivery order against McKesson's broader federal supply agreements for pharmaceutical and medical products. McKesson, a prominent healthcare services and information technology company headquartered in Irving, Texas, serves as a...
- Mckesson Corporation has been awarded a purchase order by the Department of Justice Bureau of Prisons Federal Medical Center Rochester for $2,828.91. The award has no set-aside designation and is for an open market requirement under Mckesson's FY24 B1 McKesson Open Market RP0166 contract issued in February 2024. Performance will take place in Irving, Texas with completion by March 22, 2024. The contract has a firm fixed price and unspecified items are to be provided by Mckesson, which serves...
- McKesson Corporation received a purchase order award from the Federal Medical Center Rochester, a civilian facility under the Department of Justice, for pharmaceutical and medical supplies totaling $11,468.30 on September 5, 2025. Designated as "FY25 B1 MCKESSON OPEN MARKET SEP 25 - RP 0286," this firm fixed-price contract was awarded without a set-aside designation and includes a modification (MOD 2) to increase funding by $1,192.31. The place of performance is McKesson's location...
- McKesson Corporation was awarded a Purchase Order (PO) by the Federal Medical Center Rochester for pharmaceutical and medical supplies under contract FY25 B1 MCKESSON OPEN MARKET CONTROLLED SEP 25 - RP 0284. The contract carries a ceiling value of $2,126.25 with firm fixed pricing and was awarded on September 5, 2025, with an ultimate completion date of the same day. Performance will occur at McKesson's facility in Irving, Texas. This award utilizes no small business set-aside designation and...
- Mckesson Corporation was awarded a firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Medical Center Rochester for $1,380.53. The award, identified as "FY24 B1 MCKESSON OPEN MARKET RP0174 MAR24," does not have a set-aside designation and is to be completed by March 22, 2024. No further details were provided on the specific products or services within the scope of this purchase order. Mckesson will fulfill the order requirements as the prime...
- McKesson Corporation was awarded a $325,000 delivery order contract by the Federal Medical Center Rochester on December 17, 2025, under the FY26 B1 McKesson LD Prime Vendor procurement. This firm fixed-price contract, which carries an ultimate completion date of December 17, 2025, was awarded without a set-aside designation and involves product delivery to Irving, Texas. As a prime vendor contract, this delivery order likely draws from an existing blanket purchase agreement or indefinite...
- McKesson Corporation, a leading healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a delivery order valued at $341,181.35 by the Federal Medical Center Rochester under the FY26 B1 McKesson LD Prime Vendor contract. The award, issued on December 17, 2025, utilizes a firm fixed price contract type with no set-aside designation and specifies Irving, Texas as the place of performance. This delivery order falls under McKesson's established...
- <p>Mckesson Corporation has been awarded a $5,701.65 firm fixed price purchase order by the Department of Justice's Bureau of Prisons Federal Medical Center Rochester to fulfill an open market request for unspecified products or services. As the prime contractor, Mckesson will deliver the requirements to the listed place of performance in Irving, Texas by the identified completion date of March 7, 2024. No set-aside designation was applied to this award issued directly to Mckesson.</p>
- Mckesson Corporation will provide medical supplies to the Federal Bureau of Prisons under a firm fixed price purchase order valued at approximately $1,088. The contract was awarded by the Department of Justice Bureau of Prisons' Federal Medical Center in Rochester, New York to fulfill open market requisition B1-MCKESSON RP0058. Performance will occur at Mckesson's location in Irving, Texas and span from November 28, 2023 through December 15, 2023. No subcontractors or set aside designations were...
McKesson Corporation has been awarded a firm fixed-price purchase order valued at $5,000 by the Federal Medical Center Rochester, a civilian facility under the Bureau of Prisons. The award, announced on November 1, 2025, represents an open market controlled procurement with an ultimate completion date of December 17, 2025. The contract carries no set-aside designation and will be performed at McKesson's location in Irving, Texas. This purchase order falls under the company's broader engagement with the Department of Justice's Bureau of Prisons, through which McKesson regularly supplies controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals to correctional facilities nationwide. McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been a consistent prime contractor for the federal government since its SAM.gov registration in 1999. Beyond this specific purchase order, McKesson maintains significant federal vehicles including a $25.5 million blanket purchase agreement with the Department of Homeland Security's Customs and Border Protection for medical, dental, and surgical supplies through September 2028. The company's federal contracting portfolio spans multiple agencies including the Department of Veterans Affairs, Indian Health Service, and Peace Corps, demonstrating its established capability to deliver critical medical and pharmaceutical products across diverse government programs and institutional settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/17/25 |